New FDA Requirements Should Not Apply To All Infusion Pumps, Firms Say
This article was originally published in The Gray Sheet
FDA should tailor new pre-market requirements for infusion pumps to the complexity and risks of different pump types, manufacturers say
You may also be interested in...
In response to a growing number of adverse events, FDA has asked infusion pump manufacturers to submit safety assurance cases to help understand the safety profile of their device when submitting a 510(K). But a final guidance appears to soften expectations that clinical studies always be performed to support clearance.
Republicans on the Senate HELP Committee say they are concerned that FDA is using draft guidance documents to set substantive policy, which they argue puts companies in a difficult position.
FDA issues proposed order requiring PMAs for automated external defibrillators. Allergan's Juvéderm Voluma XC dermal filler gets panel date. More regulatory news.